[Research progress of influenza type A(H1N1) vaccine and monitoring adverse reaction]
- PMID: 20726275
[Research progress of influenza type A(H1N1) vaccine and monitoring adverse reaction]
Abstract
A novel influenza type A(H1N1) virus was identified as a significant cause of acute respiratory illnesses, which spread rapidly to many countries around the world in 2009. The most effective method to prevent the outbreak of influenza type A (H1N1) was performed through large-scale immunization. Research progress and adverse reaction monitoring on influenza type A (H1N1) vaccines were reviewed.
Similar articles
-
Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program.Pediatrics. 2011 May;127 Suppl 1:S78-86. doi: 10.1542/peds.2010-1722L. Epub 2011 Apr 18. Pediatrics. 2011. PMID: 21502251 Review.
-
Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy.Expert Rev Vaccines. 2012 Aug;11(8):911-21. doi: 10.1586/erv.12.72. Expert Rev Vaccines. 2012. PMID: 23002972 Review.
-
Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.MMWR Morb Mortal Wkly Rep. 2009 Dec 11;58(48):1351-6. MMWR Morb Mortal Wkly Rep. 2009. PMID: 20010511
-
H1N1 vaccine safety monitoring: beyond background rates.Lancet. 2010 Apr 3;375(9721):1146-7. doi: 10.1016/S0140-6736(09)61917-6. Epub 2009 Oct 31. Lancet. 2010. PMID: 19880171 No abstract available.
-
Risk of fatal adverse events after H1N1 influenza vaccination.Clin Infect Dis. 2010 Jun 1;50(11):1548-9. doi: 10.1086/652719. Clin Infect Dis. 2010. PMID: 20433361 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical